Image guided, adaptive, accelerated, high dose brachytherapy as model for advanced small volume radiotherapy.
暂无分享,去创建一个
Richard Pötter | Christine Haie-Meder | Frank-André Siebert | R. Pötter | C. Haie-meder | F. Siebert | R. Pötter
[1] L. Blank,et al. Office hours pulsed brachytherapy boost in breast cancer. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[2] R. Tarducci,et al. Computed tomography for excision cavity localization and 3D-treatment planning in partial breast irradiation with high-dose-rate interstitial brachytherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] P. Maingon,et al. High-dose-rate brachytherapy for non-small-cell lung carcinoma: a retrospective study of 226 patients. , 2011, International journal of radiation oncology, biology, physics.
[4] J. Hammer,et al. Breast cancer: primary treatment with external-beam radiation therapy and high-dose-rate iridium implantation. , 1994, Radiology.
[5] Dan Ash,et al. The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[6] M. Gaztañaga,et al. Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB). , 2011, International journal of radiation oncology, biology, physics.
[7] J. Battermann,et al. Pretreatment nomogram to predict the risk of acute urinary retention after I-125 prostate brachytherapy. , 2011, International journal of radiation oncology, biology, physics.
[8] H. de Andrade Carvalho,et al. Results of high dose-rate brachytherapy boost before 2D or 3D external beam irradiation for prostate cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] J. Dimopoulos,et al. Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[10] E. van Limbergen,et al. Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[11] Kari Tanderup,et al. Reconstruction of a ring applicator using CT imaging: impact of the reconstruction method and applicator orientation , 2007, Physics in medicine and biology.
[12] L. Potters,et al. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk. , 2005, Brachytherapy.
[13] J. Dimopoulos,et al. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[14] Facundo Ballester,et al. Exclusive MRI-based tandem and colpostats reconstruction in gynaecological brachytherapy treatment planning. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[15] D. Ash,et al. Side effects of permanent I125 prostate seed implants in 667 patients treated in Leeds. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] M. Eble,et al. Evaluation of source displacement and dose--volume changes after permanent prostate brachytherapy with stranded seeds. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] Y. Yoshioka,et al. High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[18] J. Williamson,et al. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. , 2003, Medical physics.
[19] Josef Nilsson,et al. Prostate volume determination: differential volume measurements comparing CT and TRUS. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[20] B. Asselain,et al. Iridium-192 versus cobalt-60 boost in 3-7 cm breast cancer treated by irradiation alone: final results of a randomized trial. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[21] R. Pötter,et al. Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancer. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[22] Andrew See,et al. High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a Phase II trial. , 2012, International journal of radiation oncology, biology, physics.
[23] S. Nag,et al. Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[24] A. Dickler,et al. Accelerated partial breast irradiation utilizing balloon brachytherapy techniques. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[25] J. Sylvester,et al. Outcomes after prostate brachytherapy are even better than predicted , 2012, Cancer.
[26] T. Kimura,et al. Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer , 2012, International Journal of Clinical Oncology.
[27] Larry A DeWerd,et al. A dosimetric uncertainty analysis for photon-emitting brachytherapy sources: report of AAPM Task Group No. 138 and GEC-ESTRO. , 2011, Medical physics.
[28] J. Coebergh,et al. A population-based study on the utilisation rate of primary radiotherapy for prostate cancer in 4 regions in the Netherlands, 1997-2008. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[29] P. Bownes,et al. Comprehensive I-125 multi-seed comparison for prostate brachytherapy: dosimetry and visibility analysis. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[30] H. G. van der Poel,et al. The influence of geometrical changes on the dose distribution after I-125 seed implantation of the prostate. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[31] P. Hoskin,et al. High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence. , 2012, International journal of radiation oncology, biology, physics.
[32] Jean Pouliot,et al. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up. , 2009, International journal of radiation oncology, biology, physics.
[33] Masayuki Matsuo,et al. Importance of the CT/MRI fusion method as a learning tool for CT-based postimplant dosimetry in prostate brachytherapy. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[34] Shafak Aluwini,et al. HDR monotherapy for prostate cancer: a simulation study to determine the effect of catheter displacement on target coverage and normal tissue irradiation. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[35] Gerry Lowe,et al. Justification for inter-fraction correction of catheter movement in fractionated high dose-rate brachytherapy treatment of prostate cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[36] J. Battermann,et al. Results of permanent prostate brachytherapy, 13 years of experience at a single institution. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[37] J. Ciezki. Brachytherapy for localized prostate cancer. , 2009, Urology.
[38] Christian Kirisits,et al. Comparison of DVH parameters and loading patterns of standard loading, manual and inverse optimization for intracavitary brachytherapy on a subset of tandem/ovoid cases. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[39] Christian Kirisits,et al. Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[40] V. Kouloulias,et al. Brachytherapy for Prostate Cancer: A Systematic Review , 2009, Advances in urology.
[41] Benjamin M Yeh,et al. Inverse planning simulated annealing for magnetic resonance imaging-based intracavitary high-dose-rate brachytherapy for cervical cancer. , 2008, Brachytherapy.
[42] Jeremy MG Taylor,et al. Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer. , 2007, International journal of radiation oncology, biology, physics.
[43] V. Kataja,et al. Eight years experience of local prostate cancer treatment with permanent I125 seed brachytherapy--morbidity and outcome results. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[44] B. Kimmig,et al. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[45] R. Pötter,et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[46] P. Hoskin,et al. I-125 seed planning: an alternative method of urethra definition. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[47] J. Yarnold,et al. Target volume definition for external beam partial breast radiotherapy: clinical, pathological and technical studies informing current approaches. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[48] M. Maiman,et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. , 2004, Gynecologic oncology.
[49] T. Major,et al. Dosimetric experience with accelerated partial breast irradiation using image-guided interstitial brachytherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[50] U. Mahantshetty,et al. Magnetic resonance image-based dose volume parameters and clinical outcome with high dose rate brachytherapy in cervical cancers--a validation of GYN GEC-ESTRO brachytherapy recommendations. , 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).
[51] Kemal Tuncali,et al. Interventional MRI for oncologic applications. , 2007, Techniques in vascular and interventional radiology.
[52] D. Ash,et al. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[53] D. Ash,et al. Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10 years. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[54] I. Henríquez,et al. Exeresis and brachytherapy as salvage treatment for local recurrence after conservative treatment for breast cancer: results of a ten-year pilot study. , 2010, International journal of radiation oncology, biology, physics.
[55] Liying Zhang,et al. Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer? , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[56] Stefaan Vynckier,et al. Optimization of a breast implant in Brachytherapy PDR: validation with Monte Carlo simulation and measurements with TLDs and GafChromic films. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[57] S. Vanbelle,et al. Which α/β ratio and half-time of repair are useful for predicting outcomes in prostate cancer? , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[58] E. Touboul,et al. Early breast cancer: influence of type of boost (electrons vs iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[59] Richard Pötter,et al. Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer , 2010, Acta oncologica.
[60] E. van Limbergen,et al. Is this the swan song of endovascular brachytherapy? , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[61] C. Koning,et al. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[62] György Németh,et al. Conformality and homogeneity of dose distributions in interstitial implants at idealized target volumes: a comparison between the Paris and dose-point optimized systems. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[63] K. Bratengeier,et al. Prospective evaluation of quality of life after permanent prostate brachytherapy with I-125: importance of baseline symptoms and of prostate-V150. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[64] Ludvig Paul Muren,et al. Apparent Diffusion Coefficient (ADC) as a quantitative parameter in diffusion weighted MR imaging in gynecologic cancer: Dependence on b-values used , 2010, Acta oncologica.
[65] P. Levendag,et al. Quality of life of oropharyngeal cancer patients treated with brachytherapy , 2009, Current oncology reports.
[66] J. Overgaard,et al. Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[67] C. Haie-meder,et al. 152 oral DOSIMETRIC AND CLINICAL RESULTS OF A FRENCH PROSPECTIVE STUDY OF 3D BRACHYTHERAPY FOR CERVIX CARCINOMA , 2011 .
[68] A. E. Saarnak,et al. A method to improve the dose distribution of interstitial breast implants using geometrically optimized stepping source techniques and dose normalization. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[69] F. Vicini,et al. Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy. , 2011, International journal of radiation oncology, biology, physics.
[70] Kawal Rhode,et al. An analysis of intraoperative versus post-operative dosimetry with CT, CT-MRI fusion and XMR for the evaluation of permanent prostate brachytherapy implants. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[71] M. Moerland,et al. Determining DVH parameters for combined external beam and brachytherapy treatment: 3D biological dose adding for patients with cervical cancer. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[72] D. Ash,et al. Outcomes following iodine-125 monotherapy for localized prostate cancer: the results of leeds 10-year single-center brachytherapy experience. , 2010, International journal of radiation oncology, biology, physics.
[73] R. Pötter,et al. Locally recurrent breast cancer: pulse dose rate brachytherapy for repeat irradiation following lumpectomy-- a second chance to preserve the breast. , 2002, Radiology.
[74] B. Asselain,et al. Selecting patients for exclusive permanent implant prostate brachytherapy: the experience of the Paris Institut Curie/Cochin Hospital/Necker Hospital group on 809 patients. , 2008, International journal of radiation oncology, biology, physics.
[75] Christian Kirisits,et al. New inverse planning technology for image-guided cervical cancer brachytherapy: description and evaluation within a clinical frame. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[76] R. Pötter,et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[77] Aeilko H. Zwinderman,et al. 68 oral: Meta-Analysis of Survival Curves of 3 Radiotherapy Modalities on Biochemical Control and Overall Survival for the Treatment of Prostate Cancer; a Systematic Review , 2009 .
[78] A. Henderson,et al. Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical T1-T2 prostate cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[79] M. Eble,et al. Prostate-specific antigen kinetics following external-beam radiotherapy and temporary (Ir-192) or permanent (I-125) brachytherapy for prostate cancer. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[80] D. Ash,et al. The impact of hormone therapy on post-implant dosimetry and outcome following Iodine-125 implant monotherapy for localised prostate cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[81] Christian Kirisits,et al. Direct reconstruction of the Vienna applicator on MR images. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[82] L. Kestin,et al. Use of Individual Fraction Size Data from 3756 Patients to Directly Determine the α/β Ratio of Prostate Cancer , 2007 .
[83] J. Overgaard. Advancing radiation oncology through scientific publication--100 volumes of Radiotherapy and Oncology. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[84] Christine Haie-Meder,et al. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients. , 2009, International journal of radiation oncology, biology, physics.
[85] Jan J W Lagendijk,et al. A new robotic needle insertion method to minimise attendant prostate motion. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[86] H. G. van der Poel,et al. An analysis of the relation between physical characteristics of prostate I-125 seed implants and lower urinary tract symptoms: bladder hotspot dose and prostate size are significant predictors. , 2008, Radiotherapy and Oncology.
[87] Christian Kirisits,et al. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. , 2005, International journal of radiation oncology, biology, physics.
[88] P. Ágoston,et al. Moderate dose escalation with single-fraction high-dose-rate brachytherapy boost for clinically localized intermediate- and high-risk prostate cancer: 5-year outcome of the first 100 consecutively treated patients. , 2011, Brachytherapy.
[89] C. Hurkmans,et al. Dosimetric comparison of interactive planned and dynamic dose calculated prostate seed brachytherapy. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[90] Marisol De Brabandere,et al. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[91] J. Dimopoulos,et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results. , 2006, International journal of radiation oncology, biology, physics.
[92] P. Grigsby,et al. Tumor volume discrepancies between FDG-PET and MRI for cervical cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[93] J. Dimopoulos,et al. Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy. , 2012, International journal of radiation oncology, biology, physics.
[94] M. Moerland,et al. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[95] G. Gustafson,et al. High-Dose-Rate Prostate Brachytherapy: An Excellent Accelerated-Hypofractionated Treatment for Favorable Prostate Cancer , 2010, American journal of clinical oncology.
[96] Anna Niwin¯ska,et al. Cosmetic evaluation of breast conserving treatment for mammary cancer , 1998 .
[97] Gerhard Jakse,et al. Rectal dosimetry following prostate brachytherapy with stranded seeds--comparison of transrectal ultrasound intra-operative planning (day 0) and computed tomography-postplanning (day 1 vs. day 30) with special focus on sources placed close to the rectal wall. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[98] P. Hoskin,et al. Brachytherapy in the United Kingdom and Spain: a subset analysis of a European pattern of care survey , 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[99] Sasa Mutic,et al. Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET. , 2007, International journal of radiation oncology, biology, physics.
[100] Christian Kirisits,et al. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[101] C. Coles,et al. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience. , 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).
[102] J. Dimopoulos,et al. Inter- and intraobserver variation in HR-CTV contouring: intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[103] S. Yoon,et al. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. , 2007, International journal of radiation oncology, biology, physics.
[104] S. Vergez,et al. Brachytherapy in lip carcinoma: long-term results. , 2011, International journal of radiation oncology, biology, physics.
[105] H. Bartelink,et al. The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[106] K. Tai,et al. Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: mature prospective phase I/II study results. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[107] L. Incrocci,et al. Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[108] C. Haie-meder,et al. Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer. , 2011, International journal of radiation oncology, biology, physics.
[109] E. van Limbergen,et al. Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control. , 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[110] Vythialingam Sathiaseelan,et al. Intra-operative pubic arch interference during prostate seed brachytherapy in patients with CT-based pubic arch interference of < or =1cm. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[111] Y. Yoshioka,et al. Monotherapeutic high-dose-rate brachytherapy for prostate cancer: five-year results of an extreme hypofractionation regimen with 54 Gy in nine fractions. , 2011, International journal of radiation oncology, biology, physics.
[112] J. Dimopoulos,et al. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints. , 2007, International journal of radiation oncology, biology, physics.
[113] Shaleen Kumar,et al. A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[114] Christine Haie-Meder,et al. DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[115] P. Novaes,et al. The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition , 2008, International journal of medical sciences.
[116] C. Lawton. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009) , 2011 .
[117] G. Németh,et al. Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[118] K. Johansson,et al. Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[119] Marco Zaider,et al. Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[120] Kari Tanderup,et al. Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al(2)O(3):C dosimetry and a novel statistical error decision criterion. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[121] Christian Kirisits,et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results. , 2006, International journal of radiation oncology, biology, physics.
[122] Uncertainties when using only one MRI-based treatment plan for subsequent high-dose-rate tandem and ring applications in brachytherapy of cervix cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[123] J. Dimopoulos,et al. Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy. , 2011, International journal of radiation oncology, biology, physics.
[124] C. Kirisits,et al. PTV margins should not be used to compensate for uncertainties in 3D image guided intracavitary brachytherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[125] F. Foroudi,et al. Urethral stricture following high dose rate brachytherapy for prostate cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[126] C. Kirisits,et al. Concepts for critical organ dosimetry in three-dimensional image-based breast brachytherapy. , 2008, Brachytherapy.
[127] N. Schalij-Delfos,et al. Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[128] Christian Kirisits,et al. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. , 2007, International journal of radiation oncology, biology, physics.
[129] C. Marijnen. External beam radiotherapy and high dose rate brachytherapy for medically unfit and elderly patients. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).
[130] D. Baltas,et al. 3-D Conformal HDR Brachytherapy as Monotherapy for Localized Prostate Cancer , 2004, Strahlentherapie und Onkologie.
[131] Kailash Narayan,et al. Conformal brachytherapy planning for cervical cancer using transabdominal ultrasound. , 2009, International journal of radiation oncology, biology, physics.
[132] I. Trop,et al. Localization of the surgical bed using supine magnetic resonance and computed tomography scan fusion for planification of breast interstitial brachytherapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[133] P. Grigsby,et al. Dosimetric effects of air pockets around high-dose rate brachytherapy vaginal cylinders. , 2010, International journal of radiation oncology, biology, physics.
[134] M. Halliwell,et al. Magnetic resonance imaging appearances in the postoperative breast: the clinical target volume-tumor and its relationship to the chest wall. , 2008, International journal of radiation oncology, biology, physics.
[135] Y. Yamada,et al. Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT. , 2008, Brachytherapy.
[136] J. Earle,et al. Chapter 38 – Brachytherapy for Choroidal Melanoma , 2006 .
[137] J. Battermann,et al. Loose seeds versus stranded seeds in I-125 prostate brachytherapy: differences in clinical outcome. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[138] Treatment results of PDR brachytherapy combined with external beam radiotherapy in 106 patients with intermediate- to high-risk prostate cancer. , 2011, International journal of radiation oncology, biology, physics.
[139] J. Bonneterre,et al. Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[140] J. Dimopoulos,et al. Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator. , 2007, International journal of radiation oncology, biology, physics.
[141] P. Hoskin,et al. Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[142] M. Bani,et al. Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery. , 2011, International journal of radiation oncology, biology, physics.
[143] Hyun-Cheol Kang,et al. 3D CT-based high-dose-rate brachytherapy for cervical cancer: clinical impact on late rectal bleeding and local control. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[144] M. Kattan,et al. Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy. , 2009, International journal of radiation oncology, biology, physics.
[145] B. Slotman,et al. Patterns of care study for brachytherapy: results of the questionnaire for the years 2002 and 2007 in The Netherlands , 2010, Journal of contemporary brachytherapy.
[146] J. Deneufbourg,et al. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[147] R. Laing,et al. Novel prostate brachytherapy technique: improved dosimetric and clinical outcome. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[148] Inger-Karine K Kolkman-Deurloo,et al. Three-dimensional dose addition of external beam radiotherapy and brachytherapy for oropharyngeal patients using nonrigid registration. , 2011, International journal of radiation oncology, biology, physics.
[149] J. Mazeron,et al. Locoregional recurrences following radical external beam irradiation and interstitial implantation for operable breast cancer--a twenty three year experience. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[150] H. Putter,et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial , 2010, The Lancet.
[151] C. Rentsch,et al. Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[152] A. Chicheł,et al. HDR endobronchial brachytherapy (HDRBT) in the management of advanced lung cancer--comparison of two different dose schedules. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[153] Marinus A Moerland,et al. Quality of permanent prostate implants using automated delivery with seedSelectron versus manual insertion of RAPID Strands. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[154] E. van der Schueren,et al. Cosmetic evaluation of breast conserving treatment for mammary cancer. 1. Proposal of a quantitative scoring system. , 1989 .
[155] J. Wildberger,et al. Extracting atomic numbers and electron densities from a dual source dual energy CT scanner: experiments and a simulation model. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[156] R. Nout,et al. The Role of Radiotherapy in Endometrial Cancer: Current Evidence and Trends , 2011, Current oncology reports.
[157] Christian Kirisits,et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[158] Kari Tanderup,et al. Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[159] J. Langendijk,et al. External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[160] P. Hoskin,et al. High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[161] Phantom investigations on CT seed imaging for interstitial brachytherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[162] Christian Kirisits,et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[163] C. Haie-meder,et al. MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[164] G. Németh,et al. Radiotherapy Confined to the Tumor Bed Following Breast Conserving Surgery , 2002, Strahlentherapie und Onkologie.
[165] E van der Schueren,et al. Cosmetic evaluation of breast conserving treatment for mammary cancer. 1. Proposal of a quantitative scoring system. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[166] Richard Pötter,et al. Patterns of care for brachytherapy in Europe: updated results. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[167] J. Blasko,et al. Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience. , 2011, International journal of radiation oncology, biology, physics.
[168] E. Briot,et al. The source-skin distance measuring bridge: a method to avoid radiation teleangiectasia in the skin after interstitial therapy for breast cancer. , 1990, International journal of radiation oncology, biology, physics.
[169] G. Németh,et al. Electron and High-Dose-Rate Brachytherapy Boost in the Conservative Treatment of Stage I–II Breast Cancer , 2002, Strahlentherapie und Onkologie.
[170] R. Keenan,et al. Mature follow-up for high-risk stage I non-small-cell lung carcinoma treated with sublobar resection and intraoperative iodine-125 brachytherapy. , 2011, International journal of radiation oncology, biology, physics.
[171] R. Cormack,et al. Dose volume histogram analysis of normal structures associated with accelerated partial breast irradiation delivered by high dose rate brachytherapy and comparison with whole breast external beam radiotherapy fields , 2008, Radiation oncology.
[172] Alex Rijnders,et al. Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[173] J. Dimopoulos,et al. Dose volume parameter D2cc does not correlate with vaginal side effects in individual patients with cervical cancer treated within a defined treatment protocol with very high brachytherapy doses. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[174] J. Yarnold,et al. Accelerated partial breast irradiation trials: diversity in rationale and design. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[175] J. Delaloye,et al. Intravaginal Brachytherapy in FIGO Stage I Low-Risk Endometrial Cancer: A Controlled Randomized Study , 2009, International Journal of Gynecologic Cancer.
[176] J. Logue,et al. Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[177] C. Haie-meder,et al. Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer. , 2007, International journal of radiation oncology, biology, physics.
[178] Holger Borchers,et al. Low-dose rate brachytherapy for men with localized prostate cancer. , 2011, The Cochrane database of systematic reviews.
[179] T. Major,et al. Dosimetric characteristics of accelerated partial breast irradiation with CT image--based multicatheter interstitial brachytherapy: a single institution's experience. , 2011, Brachytherapy.
[180] Jan J W Lagendijk,et al. Feasibility of adequate dose coverage in permanent prostate brachytherapy using divergent needle insertion methods. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[181] Christian Kirisits,et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[182] Thorsten Schneider,et al. Realisation of the absorbed dose to water for I-125 interstitial brachytherapy sources. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[183] M. Eble,et al. Health-related quality of life after permanent I-125 brachytherapy and conformal external beam radiotherapy for prostate cancer--a matched-pair comparison. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[184] J. Mazeron. Brachytherapy: a new era. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[185] C. Haie-meder,et al. Clinical evidence on PET-CT for radiation therapy planning in cervix and endometrial cancers. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[186] Christian Kirisits,et al. Accuracy of seed reconstruction in prostate postplanning studied with a CT- and MRI-compatible phantom. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[187] R. Laing,et al. The value of Day 1 imaging following LDR prostate brachytherapy. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[188] P. Koper,et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. , 2000 .
[189] Y. Niibe,et al. Difference in rectal dosimetry between pre-plan and post-implant analysis in transperineal interstitial brachytherapy for prostate cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[190] Martin Bues,et al. Effect of random seed placement error in permanent transperineal prostate seed implant. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[191] J. Dimopoulos,et al. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results. , 2012, International journal of radiation oncology, biology, physics.
[192] Yvette Seppenwoolde,et al. HDR prostate monotherapy: dosimetric effects of implant deformation due to posture change between TRUS- and CT-imaging. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[193] R. Pötter,et al. Quality control in interstitial brachytherapy of the breast using pulsed dose rate: treatment planning and dose delivery with an Ir-192 afterloading system. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[194] Christian Kirisits,et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[195] R. Pötter,et al. Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[196] R. Fietkau,et al. Radiation exposure of the heart, lung and skin by radiation therapy for breast cancer: a dosimetric comparison between partial breast irradiation using multicatheter brachytherapy and whole breast teletherapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[197] Christian Kirisits,et al. Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[198] A. Courdi,et al. Second conservative treatment for ipsilateral breast cancer recurrence using high-dose rate interstitial brachytherapy: preliminary clinical results and evaluation of patient satisfaction. , 2011, Brachytherapy.
[199] Louis Potters,et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. , 2007, International journal of radiation oncology, biology, physics.
[200] Gerry Lowe,et al. Applicator reconstruction for HDR cervix treatment planning using images from 0.35 T open MR scanner. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[201] T. Mate,et al. Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. , 2004, International journal of radiation oncology, biology, physics.
[202] J. Crook,et al. Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[203] Christian Kirisits,et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[204] Marinus A Moerland,et al. Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: comparison between loose and stranded seed implants. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[205] Richard Pötter,et al. Image-guided brachytherapy sets benchmarks in advanced radiotherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[206] P. Koper,et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial , 2000, The Lancet.
[207] Bradley R Pieters,et al. Minimal displacement of novel self-anchoring catheters suitable for temporary prostate implants. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[208] Peter Bownes,et al. High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[209] H. Hoshi,et al. MRI-Based Preplanning in Low-Dose-Rate Prostate Brachytherapy , 2007 .
[210] Steven J Frank,et al. Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy. , 2010, International journal of radiation oncology, biology, physics.
[211] E. M. Pedersen,et al. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[212] M. Moerland,et al. The effect of alternative biological modelling parameters (α/β and half time of repair T ½ ) on reported EQD2 values in the treatment of advanced cervical cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[213] J. Persliden,et al. Phantom study of radiation doses outside the target volume brachytherapy versus external radiotherapy of early breast cancer. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[214] Kari Tanderup,et al. From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[215] H. Ackermann,et al. Hypofractionated accelerated CT-guided interstitial ¹⁹²Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[216] Kari Tanderup,et al. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. , 2008, International journal of radiation oncology, biology, physics.
[217] W. J. Morris,et al. Prostate brachytherapy post-implant dosimetry: a comparison between higher and lower source density. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[218] Robert A Cormack,et al. Sigmoid dose using 3D imaging in cervical-cancer brachytherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[219] A. Hart,et al. A comparison in cosmetic outcome between per-operative interstitial breast implants and delayed interstitial breast implants after external beam radiotherapy. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[220] K. Wallner,et al. Distant metastases following permanent interstitial brachytherapy for patients with clinically localized prostate cancer. , 2011, International journal of radiation oncology, biology, physics.
[221] H. Andersson,et al. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study. , 2012, International journal of radiation oncology, biology, physics.
[222] J. Dimopoulos,et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[223] P. Georg,et al. The use of the source-skin distance measuring bridge indeed reduces skin teleangiectasia after interstitial boost in breast conserving therapy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[224] E van der Schueren,et al. Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[225] J. Battermann,et al. Measurement of prostate rotation during insertion of needles for brachytherapy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[226] Lonneke V van de Poll-Franse,et al. Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[227] Christian Kirisits,et al. Variation of treatment planning parameters (D90 HR-CTV, D 2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[228] P. Grigsby,et al. The irradiation tolerance dose of the proximal vagina. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[229] F. Vicini,et al. The use of ultrasonography in the localization of the lumpectomy cavity for interstitial brachytherapy of the breast. , 1997, International journal of radiation oncology, biology, physics.
[230] T. Major,et al. Dosimetric comparisons between high dose rate interstitial and MammoSite balloon brachytherapy for breast cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[231] J. Dimopoulos,et al. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: A comparison of spatial dose distribution within a matched-pair analysis , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[232] Y. Yamada,et al. American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer. , 2011, Brachytherapy.
[233] P. Hoskin,et al. Prostate brachytherapy in Europe: growth, practice and guidelines. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[234] Marinus A Moerland,et al. Applicator reconstruction and applicator shifts in 3D MR-based PDR brachytherapy of cervical cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[235] E. M. Pedersen,et al. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer , 2010, Acta oncologica.
[236] U. Grouven,et al. Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: a systematic review of randomised and nonrandomised controlled clinical trials. , 2011, European urology.